Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Nifedipine, and when can generic versions of Nifedipine launch?

Nifedipine is a drug marketed by Mylan Labs Ltd, Mylan, Chase Labs Nj, Osmotica Pharm, Martec Usa Llc, Twi Pharms Inc, Osmotica Pharm Us, Heritage Pharma, Validus Pharms, Teva, Actavis Elizabeth, Valeant Pharms North, Intergel Pharm, Novast Labs Ltd, and Par Pharm. and is included in twenty-two NDAs.

The generic ingredient in NIFEDIPINE is nifedipine. There are thirty-nine drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

Summary for Tradename: NIFEDIPINE

Suppliers / Packagers: see list48
Bulk Api Vendors: see list89
Clinical Trials: see list30
Patent Applications: see list9,846
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NIFEDIPINE at DailyMed

Pharmacology for Tradename: NIFEDIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs Ltd
TABLET, EXTENDED RELEASE;ORAL202987-002Aug 25, 2016AB1RXNoNo► Subscribe► Subscribe
TABLET, EXTENDED RELEASE;ORAL201071-003Dec 3, 2010AB1RXNoNo► Subscribe► Subscribe
Novast Labs Ltd
TABLET, EXTENDED RELEASE;ORAL202987-003Aug 25, 2016AB1RXNoNo► Subscribe► Subscribe
Actavis Elizabeth
CAPSULE;ORAL072579-001Jan 8, 1991ABRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
TABLET, EXTENDED RELEASE;ORAL090602-001Sep 13, 2010AB2RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus